BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2025 1:23:02 PM | Browse: 35 | Download: 83
 |
Received |
|
2024-06-15 00:49 |
|
Peer-Review Started |
|
2024-06-15 00:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-10-29 09:09 |
|
Revised |
|
2024-11-08 10:50 |
|
Second Decision |
|
2024-12-24 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-12-25 10:24 |
|
Articles in Press |
|
2024-12-25 10:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-12-29 07:28 |
|
Publish the Manuscript Online |
|
2025-01-11 13:23 |
| ISSN |
2307-8960 (online) |
| Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Bivalirudin for anticoagulation in elderly acute coronary syndrome: Effects on myocardial microcirculation and adverse events
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chun-Yao Cheng, Wen-Rui Hao and Tzu-Hurng Cheng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung City 404328, Taiwan. thcheng@mail.cmu.edu.tw |
| Key Words |
Bivalirudin; Acute coronary syndrome; Myocardial microcirculation; Elderly patients; Anticoagulation |
| Core Tip |
While bivalirudin is more effective than heparin at reducing bleeding events and their associated risks, it has not been conclusively demonstrated to surpass heparin in improving adverse cardiac events during percutaneous coronary intervention (PCI) in elderly patients with acute coronary syndrome (ACS). However, bivalirudin has been shown to enhance myocardial microcirculation and reduce adverse cardiac events following PCI in older patients with ACS. By improving blood flow at the microvascular level and mitigating procedural risks, bivalirudin proves its potential as a superior anticoagulant. It offers a safer and more effective alternative, leading to better clinical outcomes for this high-risk patient population. Thus, bivalirudin emerges as a valuable option in the management of older patients undergoing PCI for ACS. |
| Publish Date |
2025-01-11 13:23 |
| Citation |
<p>Cheng CY, Hao WR, Cheng TH. Bivalirudin for anticoagulation in elderly acute coronary syndrome: Effects on myocardial microcirculation and adverse events. <i>World J Clin Cases</i> 2025; 13(13): 98008</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i13/98008.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i13.98008 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
